Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline. The conglomerate’s investment—which collectively ...

Dr. Joel Braunstein, CEO of C2N, says, “Samsung is an international leader and widely recognized for the seriousness and thorough reviews it undertakes in its strategic decisions. We greatly ...

It might not be the world’s most exciting update, but disappointing battery life was one of our biggest issues with the Galaxy Watch 5. It might not be the world’s most exciting update, but ...

Samsung Electronics’ medical device division showed off a selection of new artificial intelligence-based imaging tools yesterday at the Radiological Society of North America’s 2018 Annual Meeting in ...

Samsung Life Science Fund made its first strategic investment of the year into C2N Diagnostics LLC, underscoring the rising potential of blood-based diagnostics in detecting and monitoring the risk of ...

Presenting advanced image technology and clinical studies at Satellite Symposia VIENNA, March 2, 2017 /PRNewswire/ -- To empower radiologists around the world, Samsung Electronics Co., Ltd. is ...

You can usually automatically rotate the screen on your Samsung Galaxy S10 when you turn the phone horizontally. Here's how ...

GRAIL exhibits strong revenue momentum, achieving an average annual growth rate of 22.4% over the past three years versus 5.4 ...

Samsung Electronics and Samsung C&T announced on the 16th, local time, that they will invest $110 million (approximately 1.55 ...

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a $10 million USD investment from Samsung ...